Litigation Details for Silvergate Pharmaceuticals Inc. v. Bionpharma Inc. (D. Del. 2016)
✉ Email this page to a colleague
Silvergate Pharmaceuticals Inc. v. Bionpharma Inc. (D. Del. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-09-28 |
| Court | District Court, D. Delaware | Date Terminated | 2018-10-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Mitchell S. Goldberg |
| Jury Demand | None | Referred To | |
| Parties | BIONPHARMA INC. | ||
| Patents | 6,028,222; 6,977,257; 7,758,890; 8,568,747; 8,685,460; 8,778,366; 9,855,214; 9,968,553 | ||
| Attorneys | Anjali D. Deshmukh | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Silvergate Pharmaceuticals Inc. v. Bionpharma Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Silvergate Pharmaceuticals Inc. v. Bionpharma Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-16 | 147 | pertaining to U.S. Patent Nos. 8,568,747 (the “’747 patent”) and 8,778,366 (the “’366 patent”) (collectively…matter of the Patents-in-Suit or any patents or patent applications related to the Patents-in-Suit ….” …Fed. Cir. 2007). The faces of the patents-in-suit, and the U.S. Patent and Trademark Office’s electronic… Production of Assignments and Licenses of the Patents-In-Suit - filed by Bionpharma Inc.. (Attachments… PRODUCTION OF ASSIGNMENTS AND LICENSES OF THE PATENTS-IN-SUIT Defendant Bionpharma Inc. (“Defendant | External link to document | |
| 2018-04-03 | 198 | U.S. Patent No. 8,568,747 (“the ’747 Patent”) and U.S. Patent No. 8,778,366 (“the ’366 Patent”), has…include a third patent. While this patent will be litigated with the ’747 and the ’366 Patents, because claim…address only Column 19 of the ’747 Patent, the ’747 Patent and ’366 Patent share a common specification. I…of seven terms contained in the ’747 Patent and the ’366 Patent’s claims.2 1 On May 18, 2017, Chief… before the expiration of the ’747 Patent. The ’366 Patent was issued to the same inventors on | External link to document | |
| 2018-04-19 | 215 | judgment of non-infringement of U.S. Patent Nos. 8,568,747 B2 and 8,778,366 B2 - re 214 Order,,. (Dorsney, …2016 5 October 2018 1:16-cv-00876 830 Patent None District Court, D. Delaware | External link to document | |
| 2018-04-25 | 219 | non-infringement of U.S. Pat ent Nos. 8,568,747 B2 and 8,778,366 B2 by Bionpharma Inc.. (Dorsney, Kenneth) (Entered…2016 5 October 2018 1:16-cv-00876 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
